Nectero Therapeutics
PrivateLast Round
Series D
Apr 11, 2024
Est. Valuation
$170M
Total Funding Raised
$211.5M
Company Overview
Nectero Therapeutics is a clinical-stage biotechnology company developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nectero Therapeutics Comparables
Compare Nectero Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shape Memory Medical | 75% | |
| Taurus Vascular | 73% | |
| W. L. Gore & Associates | 73% | |
Nectero Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Apr 11, 2024 | ||||
| Series D | Jan 18, 2024 | ||||
| Series C | Sep 10, 2021 | ||||
| Series B | Apr 30, 2020 |
Nectero Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aphelion Capital | Series D |
| Cadence MedTech Ventures | Series D |
| Cadence Healthcare Ventures | Series D |
| Norwest Venture Partners | Series D |
| Boston Scientific Corporation | Series D, Series C |
| BioStar Capital | Series D |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 10, 2021
$20M round led by Boston Scientific Corporation and Cortex, Inc.
Nectero Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nectero Therapeutics's valuation, stock price, and market status.